HCPCS Level IIdrugActive
J0202
Injection, alemtuzumab
BETOS: O1E
Effective: 2016-01-01
Referenced in 4 policies
Description
Injection, alemtuzumab, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Lemtrada
Manufacturer
Genzyme Corporation
HCPCS Dosage
1 MG
Billing Units
12.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.